Skip to content
AUT-00063

Structure via PubChem · Public domain (PubChem)

EntityQ137049482· pop 9· linked from 2 articles

Also known as AUT00063

AUT00063 (also called AUT-00063) is an investigational small-molecule compound developed by Autifony Therapeutics for hearing loss and tinnitus.

In the Vinony graph

Within Vinony's link graph, AUT-00063 is referenced by 2 other articles, and connects out to drug, pound sterling and neuron.

Vinony files it under Abandoned drugs, Chemical articles without CAS registry number and Chemical pages without ChemSpiderID.

Its subject is documented across 9 Wikipedia language editions.

Chemical data

Formula
C20H21N3O4
Molecular weight
367.4 g/mol
IUPAC name
5,5-dimethyl-3-[6-[(4-methyl-3,4-dihydro-2H-chromen-5-yl)oxy]-3-pyridinyl]imidazolidine-2,4-dione
SMILES
CC1CCOC2=C1C(=CC=C2)OC3=NC=C(C=C3)N4C(=O)C(NC4=O)(C)C
InChIKey
FEABXCREHFVJCI-UHFFFAOYSA-N
XLogP
2.8
Polar surface area
80.8 Ų
H-bond donors
1
H-bond acceptors
5
Formal charge
0

via PubChem

Wikidata facts

Subclass of
small molecule
Mass
367.4
Has use
medication
Show 4 more facts
route of administration
oral administration
medical condition treated
hearing loss
chemical formula
C₂₀H₂₁N₃O₄
canonical SMILES
CC1CCOc2cccc(Oc3ccc(N4C(=O)NC(C)(C)C4=O)cn3)c21

via Wikidata · CC0

~2 min read

Encyclopedic overview

6 sections
Contents
  • Background and development
  • Clinical trials
  • Tinnitus (QUIET-1)
  • Mechanism of action
  • See also
  • References

AUT00063 (also called AUT-00063) is an investigational small-molecule compound developed by Autifony Therapeutics for hearing loss and tinnitus.

== Background and development ==

Excerpted from Wikipedia’s “AUT-00063” article, available under the CC BY-SA 4.0 licence.

Available in 9 languages

via Wikidata sitelinks · CC0

Connections

Categories